article · PubMed
Background: Nigeria has one of the highest burdens of zero-dose (ZD) children, those who have not received the first dose of pentavalent vaccine, despite multiple national and partner initiatives to strengthen routine immunization. A coordinated national learning agenda is required to guide evidence generation and use for reducing ZD children. The study objective is to describe the process and outcomes of a national stakeholder workshop that used a modified Delphi approach to prioritise learning questions on ZD children in Nigeria. Methodology: The Zero-Dose Learning Hub (ZDLH) convened a national workshop of immunization stakeholders from government, development partners, and civil society. A three-round modified Delphi process was used. In Round 1 (pre-workshop), participants independently scored learning questions derived from global Gavi learning priorities and Nigerian political-economy analyses. In Round 2 (during the workshop), participants discussed and re-scored questions in plenary and small groups. In Round 3 (post-workshop), participants completed a final independent ranking. Results: Ten learning questions were prioritised under three themes: equity, health systems, and innovation. The highest-ranked questions consistently focused on identifying and monitoring zero-dose & under-immunised children; understanding who and where they are and why they are missed; and health-system factors influencing their identification and measurement. Community engagement, data harmonisation, and capacity-building emerged as secondary but important areas. Conclusion: The workshop generated a nationally owned learning agenda that highlights Nigeria's most urgent evidence needs for reaching ZD children. The prioritised questions provide a practical roadmap for NPHCDA and partners to strengthen immunization equity, guide operational research, and support targeted programme implementation.
This page summarises published work. The authoritative version sits with the publisher.
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.